News
Genetic Analysis announces details of Subsequent Offering following directed issue
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, JAPAN, CANADA, NEW…
Publication of Q1 report January – March 2025
OSLO, NORWAY – May 27 2025: Genetic Analysis AS (“GA” or the “Company”) hereby publishes the interim report for the…
Genetic Analysis AS: Mandatory notification of trade
OSLO, NORWAY – 20 May 2025: Genetic Analysis AS (“GA” or “the Company”) announces that members of the Board and…
Minutes from the Annual General Meeting 2024 in Genetic Analysis AS
OSLO, NORWAY – 20 May 2025: Genetic Analysis AS (the “Company”, Ticker: GEAN) held its Annual General Meeting yesterday, May…
Notice of Annual General Meeting
OSLO, NORWAY – 5 May 2025: Notice is hereby served that the annual general meeting in Genetic Analysis AS (the…
Genetic Analysis announces proposed changes to the Board
OSLO, NORWAY – 5 May 2025: Genetic Analysis AS (the “Company”, Ticker: GEAN) today announces that its Election Committee has…
Genetic Analysis announces placement of a directed share issue of NOK 12.8 million
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, JAPAN, CANADA, NEW…
Genetic Analysis AS publishes Annual Report 2024
OSLO, NORWAY – 2 May 2025: Genetic Analysis AS (the “Company”, Ticker: GEAN) hereby publishesthe Annual Report for the financial…
Genetic Analysis AS and Thalys Medical Technology Group are pleased to announce the launch of a microbiome test to the Chinese Consumer Health market
OSLO, NORWAY/SHANGHAI, CHINA – 22. April 2025: Microbiome DX company Genetic Analysis AS (“GA”) and Thalys Medical Technology Group Corporation…
Genetic Analysis AS publishes year-end report 2024
OSLO, NORWAY – 26 February 2025: Genetic Analysis AS (the “Company”, Ticker: GEAN) hereby publishes the year-end report for the…
Genetic Analysis and Ferring Pharmaceuticals Announce A Collaboration To Develop A New Microbiome Rapid Diagnostic Test
Oslo, Norway – 20 December, 2024 – Ferring Pharmaceuticals and microbiome diagnostics specialists Genetic Analysis will bring together two established…
Genetic Analysis AS: Mandatory notification of trade – Primary Insiders
OSLO, NORWAY – 25 November 2024: Genetic Analysis AS (“GA” or “the Company”) announces that members of the management has…
Publication of Q3 Interim Report January – September 2024
OSLO, NORWAY – 15 November 2024: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) hereby publishes the third…
Publication of Half-year report 2024
OSLO, NORWAY – 30 August 2024: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) hereby publishes the interim…
Genetic Analysis AS launches the GA-map® Discovery reagent kit – a precision microbiome research assay
OSLO, NORWAY – 15 August 2024: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) announces the launch of…